Pilomyxoid astrocytoma in the adult cerebellum

Annie S Chen1, Iddo Paldor1, Alpha E Tsui2

  • 1Department of Neurosurgery, Royal Melbourne Hospital, 300 Grattan Street, Parkville, VIC 3050, Australia.

Insights

Pilomyxoid astrocytoma (PMA), a WHO Grade II tumor, is distinct from pilocytic astrocytoma (PA) and has a poorer prognosis. Emerging reports show PMA in adults, including a rare cerebellar case in a female.

Area of Science:

  • Neuro-oncology
  • Pathology
  • Neurosurgery

Background:

  • Pilomyxoid astrocytoma (PMA) is a distinct World Health Organization (WHO) Grade II tumor, previously classified as a subtype of pilocytic astrocytoma (PA).
  • PMA exhibits unique histological features and a less favorable prognosis compared to PA, with a higher tendency for recurrence and spread within the cerebrospinal fluid (CSF).

Observation:

  • While initially considered a pediatric tumor primarily affecting the hypothalamic and chiasmatic regions, PMA is increasingly reported in adults and across various neuroaxis locations.
  • This review specifically examines the literature on adult PMA cases and introduces the first documented instance of PMA occurring in the cerebellum of an adult female.

Findings:

  • Pilomyxoid astrocytoma (PMA) represents a distinct clinicopathological entity within glial tumors.
  • Adult-onset PMA, particularly in non-typical locations like the cerebellum, highlights the expanding spectrum of this tumor.
  • The poorer prognosis associated with PMA underscores the need for careful management and monitoring.

Implications:

  • Recognition of PMA as a separate entity is crucial for accurate diagnosis and prognostication.
  • Understanding the occurrence of PMA in adults and diverse locations informs clinical awareness and diagnostic approaches.
  • Further research into the biology and treatment of adult pilomyxoid astrocytoma is warranted.